If you are wondering whether Pfizer's current share price offers value or just noise, this article walks through what the numbers actually say about the stock. Pfizer's recent share price reflects ...
Pfizer cuts 2026 revenue forecast as COVID sales fade and patents expire. The firm bets on a monthly obesity drug and ...
Pfizer's oncology ambitions could start to take shape next year. The drugmaker is also likely to make progress in the weight-loss market. It might take a while longer, but Pfizer is on the path to ...
Zacks Investment Research on MSN
Pfizer (PFE) sees a more significant dip than broader market: Some facts to know
Pfizer (PFE) ended the recent trading session at $26.86, demonstrating a -1.61% change from the preceding day's closing price. The stock fell short of the S&P 500, which registered a loss of 1.52% for ...
Pfizer says it is standing behind its dividend, which makes the stock's 6.4% yield quite attractive.
Pfizer beat on 2025 sales and beat on earnings -- but still delivered a loss. Pfizer reaffirmed 2026 sales and earnings guidance for under $3 per share. 10 stocks we like better than Pfizer › Pfizer ...
Shares of Pfizer Inc. PFE rallied 1.65% to $27.05 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 1.33% to 6,740.02 and Dow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results